wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37984612-8ABCC87D-76A2-45D6-BBC7-B0A84C7F7584
Q37984612-8ABCC87D-76A2-45D6-BBC7-B0A84C7F7584
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37984612-8ABCC87D-76A2-45D6-BBC7-B0A84C7F7584
Novel targets for VEGF-independent anti-angiogenic drugs.
P2860
Q37984612-8ABCC87D-76A2-45D6-BBC7-B0A84C7F7584
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37984612-8ABCC87D-76A2-45D6-BBC7-B0A84C7F7584
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e1684222421c60157baf0d3d66d4ad98dc8677ef
P2860
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.